Registration 333-288222
- Offering price
- market-price
- Ticker
- HLXB
Company research
TheRas, Inc.
CIK 2022953Updated Oct 6, 2026
Filing activity
Latest filing
18 filings on record · 15-15D, 425, EFFECT, 424B4, CORRESP, S-4/A.
Recent filings
Show 5 more recent filings
Offerings
Registration 333-288222-01
- Offering price
- market-price
- Ticker
- HLXB
Filing attachments
ea023740105ex4-1_helix2.htm · S-4 · 2025-06-20
EX-4.1 3 ea023740105ex4-1_helix2.htm SPECIMEN COMMON STOCK CERTIFICATE OF BRIDGEBIO ONCOLOGY THERAPEUTICS, INC Exhibit 4.1 BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE COMMON STOCK This Certifies that_____________________________________________ is the owner of________________________________________________ FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK, PAR VALUE OF $0.0001 PER SHARE, OF BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (THE …
Read attachment ↗ea023740105ex99-1_helix2.htm · S-4 · 2025-06-20
EX-99.1 22 ea023740105ex99-1_helix2.htm CONSENT OF LINCOLN INTERNATIONAL LLC Exhibit 99.1 June 20, 2025 The Transaction Committee of the Board of Directors of Helix Acquisition Corp. II 200 Clarendon Street Boston, MA 02116 Re: Registration Statement on Form S-4 of Helix Acquisition Corp. II (the “Registration Statement”) Members of the Transaction Committee: Reference is made to our opinion letter, dated February 27, 2025 (the “Opinion”), with respect to the fairness, from a financi…
Read attachment ↗